A study revealed that IL-6 has the potential to facilitate the interaction between recombinant cathepsin B (CTSB) and NLRP3 via the CTSB/ATP pathway, thereby initiating the activation of the inflammasome and subsequently inducing RA. This evidence concerns the gene NLRP3 and rheumatoid arthritis.